Analysts forecast that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will announce $1.06 billion in sales for the current quarter, according to Zacks. Nine analysts have issued estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $1.03 billion to $1.08 billion. DENTSPLY SIRONA reported sales of $996.50 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 6.4%. The company is scheduled to report its next earnings report on Friday, February 16th.

On average, analysts expect that DENTSPLY SIRONA will report full year sales of $1.06 billion for the current financial year, with estimates ranging from $3.93 billion to $3.99 billion. For the next year, analysts expect that the business will post sales of $4.16 billion per share, with estimates ranging from $4.08 billion to $4.23 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same period in the previous year, the business posted $0.66 earnings per share. The business’s revenue was up 5.8% compared to the same quarter last year.

XRAY has been the topic of a number of research analyst reports. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, January 8th. Credit Suisse Group downgraded shares of DENTSPLY SIRONA to a “hold” rating and set a $73.00 price objective on the stock. in a report on Friday, January 5th. JPMorgan Chase & Co. raised shares of DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price objective on the stock in a report on Wednesday, December 13th. Deutsche Bank initiated coverage on shares of DENTSPLY SIRONA in a report on Friday, December 8th. They set a “buy” rating and a $81.00 price objective on the stock. Finally, HC Wainwright reissued a “hold” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, December 7th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $69.15.

In other DENTSPLY SIRONA news, Director Francis J. Lunger sold 8,900 shares of the company’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $65.90, for a total value of $586,510.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the sale, the director now directly owns 12,073 shares in the company, valued at approximately $821,446.92. The disclosure for this sale can be found here. 1.99% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in XRAY. BRYN MAWR TRUST Co increased its position in DENTSPLY SIRONA by 0.5% during the second quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock worth $782,000 after acquiring an additional 65 shares during the period. Nordea Investment Management AB boosted its stake in shares of DENTSPLY SIRONA by 0.7% in the 2nd quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock valued at $664,000 after purchasing an additional 75 shares in the last quarter. Security National Bank of Sioux City Iowa IA boosted its stake in shares of DENTSPLY SIRONA by 0.4% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock valued at $1,497,000 after purchasing an additional 102 shares in the last quarter. Security National Bank of SO Dak boosted its stake in shares of DENTSPLY SIRONA by 1.1% in the 2nd quarter. Security National Bank of SO Dak now owns 18,805 shares of the medical instruments supplier’s stock valued at $1,219,000 after purchasing an additional 207 shares in the last quarter. Finally, Commonwealth Bank of Australia boosted its stake in shares of DENTSPLY SIRONA by 19.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares in the last quarter. 96.13% of the stock is currently owned by institutional investors.

Shares of DENTSPLY SIRONA (XRAY) traded up $1.54 during trading on Tuesday, hitting $65.79. 1,667,100 shares of the stock were exchanged, compared to its average volume of 2,444,056. DENTSPLY SIRONA has a twelve month low of $52.53 and a twelve month high of $68.98. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $15,110.00, a price-to-earnings ratio of -18.91, a price-to-earnings-growth ratio of 2.42 and a beta of 1.31.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 12th. Shareholders of record on Friday, December 29th were issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.53%. The ex-dividend date of this dividend was Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.06%.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.watchlistnews.com/dentsply-sirona-inc-xray-expected-to-announce-quarterly-sales-of-1-06-billion/1809468.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.